These differential proteins were enriched in tumor-related pathways, including tumor growth, tumor invasion, immune response, metabolism, and signaling (RAC, FAK, CDC42, and RhoA) pathways (Fig. 2b, Supplementary Data 2, 3). Here, CDC42 is linked to neoplasm.